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Abstract We examined the expression of GKLF (gut-enriched 
Kriippel-like factor), a recently identified zinc finger-containing 
transcription factor, in mice during development using the 
ribonuclease protection assay. In the adult, the level of GKLF 
transcript is abundant throughout the gastrointestinal tract. 
Between embryonic days 10 and 19 (E10 and E19) of 
development, the initial level of whole embryo GKLF transcript 
is low but begins to rise on El 3 and peaks on El 7. In the 
newborn, GKLF transcript level is higher in the colon than in the 
small intestine although the levels in both organs rise with 
increasing age. Expression of GKLF was also examined in the 
intestinal tract of the Min mouse, a model of intestinal 
tumorigenesis. The level of GKLF transcript is significantly 
decreased in the intestine of Min mice during a period of tumor 
formation when compared to age-matched control littermates. 
Our findings indicate that GKLF expression correlates with 
certain periods of gut development and is down-regulated during 
intestinal tumorigenesis, suggesting that GKLF may play a role 
in gut development and/or tumor formation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The mammalian intestinal epithelium is divided into several 
distinct compartments within which fundamentally different 
cellular processes are observed [1,2]. Stem cells reside in the 
intestinal crypts where they rapidly proliferate to produce 
descendants that migrate along the crypt-to-villus axis. Dur-
ing migration, cells cease to divide and differentiate into ma-
ture cells with characteristics of enterocytes. At the apex of 
the villus, cells undergo programmed cell death and are ex-
foliated. This process of proliferation, migration, differentia-
tion, and exfoliation is completed in 3-5 days in the small 
intestine of the adult mouse [3]. The intestinal epithelium 
therefore represents an attractive system in which the dynam-
ics of these important biological processes can be studied. 
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The complex structure of the adult intestinal epithelium is 
established during late fetal development. In the mouse, the 
gut endoderm is poorly differentiated before embryonic day 
15 (E15). Between E15 and E18, the pseudostratified gut epi-
thelium undergoes dramatic remodeling which is coupled with 
cytodifferentiation to form a simple columnar epithelium [4]. 
Accompanying this process is the induction of intestine-spe-
cific genes that encode proteins necessary for intestinal func-
tion following birth [5]. Development of the adult crypt struc-
ture occurs during the first two weeks after birth [6]. 
Thereafter, dramatic changes in gene expression are seen dur-
ing the suckling-weaning transition period and after which the 
adult phenotype is eventually established [7]. It is now widely 
accepted that gene transcription plays an essential role in the 
development of gut epithelial function and many recent stud-
ies have begun to unravel the mechanisms controlling gut-
specific gene expression [5]. 
Because of its rapid turnover and exposure to environmen-
tal carcinogens, the gut epithelium is relatively susceptible to 
neoplastic transformation. This is exemplified by the high 
prevalence of colon cancer in humans, especially in the west-
ern world [8]. Recently, the genetic basis of colon cancer has 
partially been deciphered by the identification of gene muta-
tions that occur in families with a hereditary predisposition to 
colon cancer. A well-known example is the autosomal domi-
nant familial adenomatous polyposis (FAP) syndrome [9]. In-
dividuals affected by FAP carry a single mutant alíele of the 
adenomatous polyposis coli (APC) gene [10,11]. Importantly, 
a murine model of FAP was independently developed in 
C57BL/6J mice that had been treated with the mutagen ethy-
nitrosourea and bred for germline transmission [12]. The mu-
tation that predisposes the formation of intestinal polyps in 
this Min (multiple intestinal neoplasia) mouse model was 
identified as the murine homologue of human APC [13]. 
Thus, an analysis of this mouse model should greatly facilitate 
our understanding of the molecular mechanisms responsible 
for intestinal neoplasia. 
We recently identified and isolated a murine cDNA clone, 
named GKLF (gut-enriched Krüppel-like factor), that en-
codes a novel transcription factor with three C2H2 zinc fingers 
of the Krüppel type [14]. Expression of GKLF is enriched in 
the intestinal tract with the highest level of transcript found in 
the differentiated epithelial cells of the colonic mucosa. In cell 
culture, expression of GKLF is induced under conditions that 
promote growth arrest such as serum deprivation and contact 
inhibition. Moreover, enforced expression of GKLF in trans-
fected cells results in the inhibition of DNA synthesis. Taken 
together, these observations suggest that GKLFs have an im-
portant function in regulating growth of intestinal epithelial 
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cells. Subsequently, GKLF was independently identified by a 
second group and shown to be expressed also at high levels in 
the epidermal layers of the skin [15]. These results suggest that 
GKLF may also be involved in the terminal differentiation of 
select epithelial tissues. 
To further understand the function of GKLF, we examined 
its expression during development and intestinal tumorigene-
sis. We show that changes in GKLF expression correlate with 
an important landmark period of intestinal development -
during morphogenesis of the embryonic gut epithelium. More-
over, we show that expression of GKLF is significantly de-
creased in the intestine of the Min mouse during a period in 
which tumor formation occurs. These findings are suggestive 
of a purported function of GKLF in regulating growth and 
differentiation of intestinal epithelial cells. 
2. Materials and methods 
2.1. Animals and preparation of RNA from tissues 
Wild-type (+/+) and Min (Min/+) C57BL/6J mice were purchased 
from the Jackson Laboratory (Bar Harbor, ME). The Min pedigree 
was maintained by crossing Min/+ males with C57BL/6J +/+ females. 
The Minl+ animals were identified by an allele-specific polymerase 
chain reaction as previously described [16]. +/+ littermates were 
used as controls. All animals were killed by CO2 asphyxiation in 
accordance with the protocol of the Johns Hopkins University. Total 
RNA was extracted from snap-frozen whole embryos or various seg-
ments of the intestine using the TRIzol Reagent purchased from LIFE 
Technologies (Gaithersburg, MD). After determining the concentra-
tion of the RNA samples by optical density measurement, their in-
tegrity and quantity were verified with denaturing agarose gel electro-
phoresis before the ribonuclease protection assay. 
2.2. Ribonuclease protection assay (RPA) 
An Apal-BspMI restriction endonuclease fragment of the GKLF 
cDNA between nt 1360 and 1570 [14] was subcloned into the plasmid 
pBluescript (Stratagene (La Jolla, CA)) and used to generate a 32P-
labeled antisense RNA probe using T3 RNA polymerase. The pTRI-
Actin plasmid- (Ambion Inc. (Austin, TX)) containing part of the 
mouse ß-actin cDNA was used to generate an antisense ß-actin probe 
with T3 RNA polymerase and used as a control for RNA loading in 
all experiments. Probes were synthesized from linearized plasmid tem-
plates by in vitro transcription with the designated RNA polymerase 
and [a-32P]UTP (NEN-DuPont (Boston, MA)) using the MAXIscript 
protocol provided by Ambion Inc. The size of the synthesized probe 
for GKLF and ß-actin was 277 nt and 300 nt, respectively. The size of 
the resultant fragment following ribonuclease protection assay was 
220 nt and 250 nt for GKLF and ß-actin, respectively. 
RPA was performed according to the protocol provided by Ambion 
Inc. Briefly, 20 ug of total RNA were mixed with 3xl05 cpm of 
labeled probe (GKLF or ß-actin) and precipitated with ethanol after 
addition of NH4OAc to 0.5 M. A control reaction containing 20 |lg of 
yeast tRNA instead of mouse RNA was performed in all experiments. 
The precipitated samples were collected by centrifugation and sus-
pended in 20 ul of hybridization buffer containing 300 mM NaOAc, 
100 mM NaCitrate, pH 6.4, 1 mM EDTA, and 80% formamide. 
Following heating to 95°C for 5 min to denature the RNA, samples 
were annealed at 55°C for 24 h. At the completion of hybridization, 
200 ul of a diluted RNase mixture containing a 1:50 dilution of a 
mixture of 0.5 mg/ml RNase A and 10000 units/ml RNase Tl were 
added to each sample and incubated at 37°C for 30 min. The reactions 
were stopped by the addition of 300 ul of an RNase inactivation/ 
precipitation solution (Ambion Inc.) and the samples precipitated 
with ethanol. The protected products were resolved on a 6% sequenc-
ing gel and visualized by autoradiography. Radioactively labeled 
RNA size markers provided by the manufacturer were also run on 
the same gel. 
3. Results 
Ribonuclease protection assay (RPA) was first performed 
on total RNA isolated from various regions of the gastro-
intestinal tract of a 4 month-old wild-type C57BL/6J mouse 
using a 32P-labeled riboprobe prepared from GKLF or ß-actin 
cDNA. Lane 8 of Fig. 1 shows the size of the probe - 277 nt 
for GKLF (upper panel) and 300 nt for ß-actin (lower panel). 
When various segments of intestinal tissues were analyzed, a 
single, prominent protected band of 220 nt was noted for 
GKLF (arrow, upper panel). This size is consistent with the 
predicted size based on the cDNA sequence. Similarly, a pro-
tected fragment of 250 nt was noted when samples were hy-
bridized to the ß-actin probe (arrow, lower panel). No pro-
tected fragments were seen when yeast tRNA was hybridized 
to either the GKLF or ß-actin probe (lane 7). Fig. 1 shows 
that the level of GKLF transcript is high throughout the 
gastrointestinal tract in the 4 month-old mouse with the ex-
ception of the proximal small intestine, which contains a 
slightly lower amount of GKLF mRNA. In addition, the liver 
contains no GKLF transcript, an observation consistent with 
our previous finding [14]. Overall, the relative amounts of 
GKLF transcript in the intestinal tissues as revealed by 
RPA are in accord with the results of our previous study 
using Northern blot analysis [14]. 
The expression of GKLF in whole mouse embryos during 
development was subsequently determined between E10 and 
E19. RNA was isolated from pooled embryos during each day 
of the development and multiple pools were independently 
analyzed. Shown in Fig. 2 is a representative result of these 
studies. The result indicates that GKLF transcript is very low 
from E10 to El2, and only begins to rise on El3. The level of 
the transcript peaks on El7 before decreasing moderately by 
E19. The absolute level of GKLF transcript at E17 is perhaps 
even higher than shown in Fig. 2, considering that RNA from 
this day is underloaded (lane 13, lower panel). As a reference, 
Fig. 1. RPA of GKLF transcripts in the adult mouse gastrointesti-
nal tract. Tissues were obtained from a 4 month-old wild-type 
C57BL/6J mouse. SI is small intestine. Twenty ug of total RNA 
from each tissue were hybridized to GKLF or ß-actin riboprobe. 
Arrows indicate the protected fragments. Sizes of molecular mass 
markers are shown on the right. Lane 7 is a control containing 
yeast tRNA only and lane 8 is probe only. 
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Fig. 2. RPA of GKLF transcripts during fetal development. Total RNA was extracted from whole mouse embryos between ElO and E19 of de-
velopment. Twenty ug from each day were used in the experiment to measure either GKLF or ß-actin transcripts. As a comparison, 20 ug of 
RNA from tissues of a 4 week-old mouse were included in the experiment. Lanes 1, 16, and 17 contain yeast tRNA and lane 19 is probe only. 
RNA from various regions of a 4 week-old mouse was also 
analyzed in the same experiment (lanes 2 to 5). 
Expression of GKLF was also examined in intestinal tissues 
obtained from C57BL/6J mice between days 4 (P4) and 210 
(P210) of postnatal development. RNA samples from whole 
small intestine and whole colon were analyzed (Fig. 3). At 
birth, the level of GKLF transcript is higher in the colon 
than in the small intestine. The levels in both organs rise 
gradually with increasing age and peak at 75 days after birth. 
The overall GKLF transcript level in the colon at each given 
time point is higher than that in the small intestine because of 
underloading of the colonic samples as judged by the ß-actin 
levels (compare lanes 6-10 to lanes 1-5, lower panel). 
Because expression of GKLF has been shown to be associ-
ated with growth arrest, we examined its expression in the 
Min mouse, a model of intestinal tumorigenesis and deregu-
lated proliferation. RPA was performed on RNA obtained 
from multiple pools of whole small intestine and whole colon 
of Min mice and compared to wild-type mice between weeks 6 
and 15 after birth (Figs. 4 and 5). In the C57BL/6J Minl+ 
mouse, intestinal tumors are typically first noted at the 9th 
week after birth and increase in size from then on. These mice 
usually do not survive beyond 17 weeks of life due to tumor 
burden [12,17]. The average number of tumors developed in 
the intestinal tract of closely related pedigrees to our Minl+ 
mice is consistent with previously published report - 24 in the 
small intestine and 5 in the colon [17]. As seen in Fig. 4, the 
level of GKLF transcript is fairly equal in the small intestine 
of wild-type and Min mice at weeks 6 and 9. However, there is 
a significant decrease in the GKLF message level in the small 
intestine of Min mice as compared to the wild-type mice at 
weeks 12 and 15 (compare lanes 6 to 5 and lanes 8 to 7, Fig. 
4). This difference is much less pronounced when RNA from 
whole colon of wild-type and Min mice were analyzed (Fig. 5). 
Fig. 3. RPA of GKLF transcripts in the intestines during postnatal development. RNA was extracted from whole small intestine or whole co-
lon from mice at the stated days following birth (P4 to P210). Twenty ug of RNA were used in each lane. 
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4. Discussion 
GKLF was originally identified based on DNA homology 
to the zinc finger region of a related Krüppel protein, zif268 
[14]. The amino acid sequence outside the zinc finger region of 
GKLF, however, is unique. Of all the Krüppel related pro-
teins, the zinc finger sequences of two transcription factors, 
erythroid Krüppel-like factor (EKLF [18]) and lung Krüppel-
like factor (LKLF [19]), are most similar to that of GKLF. A 
recent study showed that the nuclear localization signals of 
these three proteins are also conserved [20]. Each of these 
proteins is expressed in a tissue-selective fashion, and EKLF 
has been shown to be an essential factor for hematopoiesis 
[21,22]. 
Our previous study showed that GKLF is expressed in a 
tissue-selective manner, notably at high levels in the gastro-
intestinal tract [14]. In addition, GKLF is expressed in the skin 
[15]. Furthermore, in situ hybridization experiments showed 
that GKLF is specifically expressed in the differentiated epi-
thelial cells of both intestine and skin [14,15]. Combined with 
the growth arrest-associated nature of GKLF [14], it is possi-
ble that GKLF has an important regulatory function during 
terminal differentiation of specific epithelial cells. These obser-
vations provided the rationale for the current study to exam-
ine expression of GKLF during development. 
Consistent with the hypothesis that GKLF plays a role in 
regulating epithelial differentiation, we found that GKLF is 
expressed during a critical period of fetal development when 
the gut epithelium undergoes major transition from a pseu-
dostratified to a columnar structure between El5 and El8 
(Fig. 2). These findings demonstrate a correlation between 
GKLF expression and an important 'landmark' stage of gut 
epithelial development, which lends support to the hypothesis 
that GKLF may be involved in regulating intestinal epithelial 
differentiation. 
The decreased expression of GKLF in the small intestine of 
Min mice during the period of intestinal tumorigenesis is in-
triguing. However, this is not entirely surprising since GKLF 
is expressed in growth-arrested cells [14]. As the adenomatous 
epithelium in the Min intestine is a model of deregulated pro-
liferation, it is possible that the level of GKLF transcript is 
Fig. 5. RPA of GKLF transcripts in the colon of wild-type and 
Min mice. Total RNA was extracted from whole colon of wild-type 
(+/+) or Min (Min/+) mice at the indicated time points after birth. 
In this experiment, 10 |ig of RNA were used in each lane. 
decreased in the adenomas themselves. The less apparent de-
crease of GKLF transcript level in the colon of Min mice 
when compared to the wild-type controls supports this notion 
since the Min mice develop significantly fewer tumors in the 
colon as compared to the small intestine [12,17]. It remains to 
be seen, however, whether the decreased expression of GKLF 
occurs during the initiation of tumorigenesis or is simply a 
result of tumor formation due to increased proliferation and/ 
or decreased differentiation. 
It is of interest to note that there are several similarities in 
the pattern of expression of GKLF and the gene encoding 
another intestine-specific transcription factor, Cdx-2. Cdx-2 
is a homeobox-containing nuclear protein specifically ex-
pressed in the gut epithelium [23]. In the adult mouse, the 
level of Cdx-2 transcript is higher in the colon than the small 
intestine. During embryogenesis, expression of Cdx-2 is sig-
nificantly up-regulated in the small and large intestine between 
E16 and E18 [24]. In addition, in both human and rat color-
ectal adenoma and carcinoma, the level of Cdx-2 protein is 
markedly reduced [25]. These observations are reminiscent of 
those for GKLF reported in this and previous studies [14,15]. 
Furthermore, the importance of Cdx-2 in regulating intestinal 
epithelial proliferation is demonstrated by a recent study in 
which mice with targeted ablation of Cdx-2 was shown to 
develop intestinal polyposis [26]. It remains formally possible 
that GKLF has a similar function and similar gene targeting 
experiments may help to clarify the role of GKLF in the 
control of intestinal epithelial proliferation. 
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